MitoScience LLC Awarded Qualifying Therapeutic Grant to Advance Screening Assays for Drug Development in Cancer

EUGENE, Ore.--(BUSINESS WIRE)--MitoSciences Inc. today announces that it has been awarded a $244,000 grant under the IRS Qualifying Therapeutic Discovery Project. This award was made in support of MitoSciences' efforts to develop the world's most advanced set of assays for unlocking the role of metabolism in cancer and other critical diseases, and for helping researchers to design and monitor the most effective therapies for those conditions.